Results 11 to 20 of about 8,229 (214)

The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer.

open access: yesPLoS ONE
Ovarian cancer is the leading cause of death among gynecologic malignancies. Despite recent advancements in targeted therapies such as PARP inhibitors, recurrence is common and frequently resistant to existing therapies.
Kyukwang Kim   +8 more
doaj   +5 more sources

Isotopic purification of He4.

open access: yesCryogenics, 1976
Isotopic purification of He4 is conventionally accomplished by 'filtration' through a superleak which may, for example, be of compressed rouge or of Vicor glass.
Atkins, M., McClintock, Peter V. E.
core   +6 more sources

Usefulness of serum HE4 in endometriotic cysts. [PDF]

open access: yesBritish Journal of Cancer, 2009
Usefulness of serum HE4 in endometriotic ...
GUIDI, Giancesare   +9 more
core   +5 more sources

Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6 [PDF]

open access: yesFrontiers in Pharmacology, 2019
While selective overexpression of serum clinical biomarker Human epididymis secretory protein 4 (HE4) is indicative of ovarian cancer tumorigenesis, much is still known about the mechanistic role of the HE4 gene or gene product. Here, we examine the role
Nicole E. James   +14 more
doaj   +2 more sources

HE4 Levels in Ovarian Cancer-Resistant Menopausal Women

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2019
Objective: To analyse the predictive value of HE4 in ovarian cancer patients according to their resistance and menopausal status Methods: Thirteen premenopausal and twenty-five menopausal ovarian cancer patients were measured for HE4 levels measured ...
Wiwi Irawan   +3 more
doaj   +2 more sources

The Establishment of an HE4‐CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer [PDF]

open access: yesJournal of Clinical Laboratory Analysis, 2016
BackgroundThe human epididymal secretory protein 4 (HE4) is a novel, verified biomarker for the early diagnosis of ovarian cancer.MethodsMagnetic beads were coated with capture antibodies and were used with acridinium ester labeled detection antibodies in a sandwich‐type immunoassay.
Qiong, Zhang   +4 more
openaire   +2 more sources

The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses [PDF]

open access: yes, 2011
Background: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy.
Fuerst, Sophie   +19 more
core   +1 more source

Evaluation of tumor marker HE4 assay on the Elecsys 2010 analyzer

open access: yesJournal of Health Sciences, 2014
Introduction: Whey-acidic protein human epididymis protein 4 (HE4) is a new promising biomarker for epithelial ovarian cancer. The measured HE4 values may depend on the testing procedure used.
Jozo Ćorić   +3 more
doaj   +1 more source

Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK/STAT3 pathway

open access: yesBiology Open, 2019
Human epididymis protein 4 (HE4) is well known to be a predictor of ovarian cancer clinically. HE4 is reported to play crucial roles in ovarian cancer progression and metastasis.
Aihong Wang   +4 more
doaj   +1 more source

Hypoxia-Induced Upregulation of HE4 Is Responsible for Resistance to Radiation Therapy of Gastric Cancer

open access: yesMolecular Therapy: Oncolytics, 2019
Upregulation of human epididymis protein 4 (HE4) is often observed in different types of cancers, including gastric cancer (GC), but the association of elevated HE4 level with radiation resistance in GC remains unclear.
Chunwei Peng   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy